Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia (Q44884500)

7 December 2017

title

Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia (English)

1 reference

7 December 2017

0 references

0 references

Sema Uslu

1

1 reference

7 December 2017

Zubeyde Eken Akarkarasu

2

1 reference

7 December 2017

Demet Ozbabalik

3

1 reference

7 December 2017

Serhat Ozkan

4

1 reference

7 December 2017

Omer Colak

5

1 reference

7 December 2017

Emine Sutken Demirkan

6

1 reference

7 December 2017

Ayşe Ozkiris

7

1 reference

7 December 2017

Canan Demirustu

8

1 reference

7 December 2017

Ozkan Alatas

9

1 reference

7 December 2017

language of work or name

1 reference

22 March 2012

1 reference

7 December 2017

published in

Neurochemical Research

1 reference

7 December 2017

volume

37

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1554-1559

1 reference

Pharmacotherapy and prevention of vascular dementia

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

The role of inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Neuroinflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Circulating biomarkers of cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma ß-amyloid and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

A meta-analysis of cytokines in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Interleukin-6, a mental cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Increased production of inflammatory cytokines in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Body mass index in midlife and risk of Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Body mass index (BMI) at an early age and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0750-0

Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients.

21 January 2018

1 reference

12 December 2020

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

1 reference

12 December 2020

10.1007/S11064-012-0750-0

Identifiers

DOI

1 reference

7 December 2017

1 reference